Community Gateway to Health Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHarvard School of Public Health (HSPH)
About this trial
The goal of this study is to evaluate the impact of a multi-level intervention on cancer prevention and social determinants of health outcomes. This partnership between academic and community-based researchers aims to link community health centers and communities in ways that maximize both civic engagement and participation in cancer control care. The system-level intervention consists of two components: (1) provision of community health center systems-level tools for cancer screening (breast, cervical, colorectal) and tobacco cessation treatment gaps; and (2) digital access screening and navigation. These interventions will be delivered via usual care.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Community health center staff or community partners
Age 18 or older
Disqualifiers
Under 18
Trial design
Design model
Sequential
Treatments tested in this trial
Tools and Training for Cancer Control
BehavioralThis system level intervention consists of two components: (1) provision of community health center systems-level tools for cancer screening (breast, cervical, colorectal) and tobacco cessation treatment gaps; and (2) digital access screening and navigation.
Enhancing Social Capital and Civic Engagement
BehavioralThis community level intervention consists of a patient referral from a community health center to a community organization focused on building social capital and civic engagement to test the impact of connecting clinical and community resources explicitly for patients.
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: Multilevel InterventionExperimental treatment 2 interventions
Group B: Usual CareNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Patients Screened for Colorectal Cancer
% patients who are up to date on colorectal cancer screening from EMR
Time frame
change from baseline to end of intervention period, an average of 1 year2
Patients Screened for Breast Cancer
% patients who are up to date on breast cancer screening from EMR
Time frame
change from baseline to end of intervention period, an average of 1 year3
Patients Screened for Cervical Cancer
% patients who are up to date on cervical cancer screening from EMR
Time frame
change from baseline to end of intervention period, an average of 1 year4
Patients Offered Pharmacotherapy for Smoking Cessation
% patients offered pharmacotherapy from EMR
Time frame
change from baseline to end of intervention period, an average of 1 yearSecondary outcomes
1
Acceptability of the intervention
Self reported via staff survey
Time frame
Post intervention, 1 year follow up2
Feasibility of the intervention
Self-reported via staff survey
Time frame
Post intervention, 1 year follow upLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Harvard School of Public Health (HSPH)
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Caring Health Center
Collaborator
Massachusetts League of Community Health Centers
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: